Search

Your search keyword '"Gras, Luuk"' showing total 9 results
Start Over Author "Gras, Luuk" Publisher springer science and business media llc
9 results on '"Gras, Luuk"'

1. Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—The DIADEM study from the chronic malignancies working party of the EBMT

Author

Waszczuk-Gajda, Anna, primary, Gras, Luuk, additional, de Wreede, Liesbeth C., additional, Sirait, Tiarlan, additional, Illes, Arpad, additional, Ozkurt, Zubeyde Nur, additional, Snowden, John A., additional, Arat, Mutlu, additional, Bulabois, Claude Eric, additional, Niederland, Judith, additional, Sever, Matjaz, additional, Paneesha, Shankara, additional, Potter, Victoria, additional, Gadisseur, Alain, additional, Chalopin, Thomas, additional, Van Gorkom, Gwendolyn, additional, López, Joaquin Martínez, additional, Kerre, Tessa, additional, Drozd-Sokolowska, Joanna, additional, Raj, Kavita, additional, Hayden, Patrick J., additional, Beksac, Meral, additional, Yakoub-Agha, Ibrahim, additional, McLornan, Donal P., additional, and Schönland, Stefan, additional

Published
2023
Full Text
View/download PDF

2. Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable – a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Author

Drozd-Sokolowska, Joanna, primary, Gras, Luuk, additional, Zinger, Nienke, additional, Zahrani, Mohsen Al, additional, Passweg, Jakob, additional, Byrne, Jenny, additional, Ho, Aloysius, additional, Huang, Xiao-jun, additional, Kröger, Nicolaus, additional, Mayer, Jiri, additional, Russo, Domenico, additional, De Becker, Ann, additional, Tbakhi, Abdelghani, additional, Stamatoullas, Aspasia, additional, Valerius, Thomas, additional, Hayden, Patrick, additional, McLornan, Donal P., additional, Onida, Francesco, additional, Scheid, Christof, additional, Robin, Marie, additional, and Yakoub-Agha, Ibrahim, additional

Published
2022
Full Text
View/download PDF

3. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT

Author

UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service d'hématologie, Drozd-Sokołowska, Joanna, Gras, Luuk, Zinger, Nienke, Snowden, John A., Arat, Mutlu, Basak, Grzegorz, Pouli, Anastasia, Crawley, Charles, Wilson, Keith M. O., Tilly, Herve, Byrne, Jennifer, Bulabois, Claude Eric, Passweg, Jakob, Ozkurt, Zubeyde Nur, Schroyens, Wilfried, Lioure, Bruno, Colorado Araujo, Mercedes, Poiré, Xavier, Van Gorkom, Gwendolyn, Gurman, Gunhan, de Wreede, Liesbeth C., Hayden, Patrick J., Beksac, Meral, Schönland, Stefan O., Yakoub-Agha, Ibrahim, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service d'hématologie, Drozd-Sokołowska, Joanna, Gras, Luuk, Zinger, Nienke, Snowden, John A., Arat, Mutlu, Basak, Grzegorz, Pouli, Anastasia, Crawley, Charles, Wilson, Keith M. O., Tilly, Herve, Byrne, Jennifer, Bulabois, Claude Eric, Passweg, Jakob, Ozkurt, Zubeyde Nur, Schroyens, Wilfried, Lioure, Bruno, Colorado Araujo, Mercedes, Poiré, Xavier, Van Gorkom, Gwendolyn, Gurman, Gunhan, de Wreede, Liesbeth C., Hayden, Patrick J., Beksac, Meral, Schönland, Stefan O., and Yakoub-Agha, Ibrahim

Abstract

Autologous hematopoietic cell transplantation (auto-HCT) may be performed in multiple myeloma (MM) patients relapsing after a previous auto-HCT. For those without an adequate dose of stored stem cells, remobilization is necessary. This retrospective study included patients who, following disease relapse after the first auto-HCT(s), underwent stem cell remobilization and auto-HCT performed using these cells. There were 305 patients, 68% male, median age at salvage auto-HCT was 59 years. The median time to relapse after the first-line penultimate auto-HCT(s) was 30.6 months, the median follow-up after salvage auto-HCT 31 months. The 2- and 4-year non-relapse mortality (NRM) after the salvage auto-HCT was 5 and 9%, the relapse incidence 56 and 76%, respectively. Overall survival (OS) after 2 and 4 years was 76 and 52%, progression-free survival (PFS) 39 and 15%. In multivariable analysis an increasing interval between the penultimate auto-HCT and relapse was associated with better OS and PFS, later calendar year of salvage auto-HCT with better OS. In conclusion, salvage auto-HCT performed with cells remobilized after a previous auto-HCT was associated with acceptable NRM. The leading cause of failure was disease progression of MM, which correlated with a shorter interval from the penultimate auto-HCT to the first relapse.

Published
2022

4. Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT

Author

Hernández-Boluda, Juan-Carlos, primary, Pereira, Arturo, additional, Zinger, Nienke, additional, Gras, Luuk, additional, Martino, Rodrigo, additional, Nikolousis, Emmanouil, additional, Finke, Jürgen, additional, Chinea, Anabelle, additional, Rambaldi, Alessandro, additional, Robin, Marie, additional, Saccardi, Riccardo, additional, Natale, Annalisa, additional, Snowden, John A., additional, Tsirigotis, Panagiotis, additional, Vallejo, Carlos, additional, Wulf, Gerald, additional, Xicoy, Blanca, additional, Russo, Domenico, additional, Maertens, Johan, additional, Daguindau, Etienne, additional, Lenhoff, Stig, additional, Hayden, Patrick, additional, Czerw, Tomasz, additional, McLornan, Donal P., additional, and Yakoub-Agha, Ibrahim, additional

Published
2022
Full Text
View/download PDF

5. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT

Author

Drozd-Sokołowska, Joanna, primary, Gras, Luuk, additional, Zinger, Nienke, additional, Snowden, John A., additional, Arat, Mutlu, additional, Basak, Grzegorz, additional, Pouli, Anastasia, additional, Crawley, Charles, additional, Wilson, Keith M. O., additional, Tilly, Herve, additional, Byrne, Jennifer, additional, Bulabois, Claude Eric, additional, Passweg, Jakob, additional, Ozkurt, Zubeyde Nur, additional, Schroyens, Wilfried, additional, Lioure, Bruno, additional, Colorado Araujo, Mercedes, additional, Poiré, Xavier, additional, Van Gorkom, Gwendolyn, additional, Gurman, Gunhan, additional, de Wreede, Liesbeth C., additional, Hayden, Patrick J., additional, Beksac, Meral, additional, Schönland, Stefan O., additional, and Yakoub-Agha, Ibrahim, additional

Published
2022
Full Text
View/download PDF

6. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT

Author

Hernández-Boluda, Juan-Carlos, primary, Pereira, Arturo, additional, Zinger, Nienke, additional, Gras, Luuk, additional, Martino, Rodrigo, additional, Nikolousis, Emmanouil, additional, Finke, Jürgen, additional, Chinea, Anabelle, additional, Rambaldi, Alessandro, additional, Robin, Marie, additional, Saccardi, Riccardo, additional, Natale, Annalisa, additional, Snowden, John A., additional, Tsirigotis, Panagiotis, additional, Vallejo, Carlos, additional, Wulf, Gerald, additional, Xicoy, Blanca, additional, Russo, Domenico, additional, Maertens, Johan, additional, Daguindau, Etienne, additional, Lenhoff, Stig, additional, Hayden, Patrick, additional, Czerw, Tomasz, additional, McLornan, Donal P., additional, and Yakoub-Agha, Ibrahim, additional

Published
2022
Full Text
View/download PDF

7. Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT

Author

Vincent, Laure, primary, Gras, Luuk, additional, Ceballos, Patrice, additional, Finke, Jürgen, additional, Passweg, Jakob, additional, Harel, Stéphanie, additional, Rosinol, Laura, additional, Minnema, Monique, additional, Teipel, Raphael, additional, van Doesum, Jaap, additional, Hänel, Mathias, additional, Lenain, Pascal, additional, Botella-Garcia, Carmen, additional, Koenecke, Christian, additional, Ducastelle, Sophie, additional, Sanz, Jaime, additional, Schroyens, Wilfried, additional, Zuckerman, Tsila, additional, Monaco, Federico, additional, Koster, Linda, additional, de Wreede, Liesbeth, additional, Hayden, Patrick J., additional, Schönland, Stefan, additional, Yakoub-Agha, Ibrahim, additional, and Beksac, Meral, additional

Published
2022
Full Text
View/download PDF

8. Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach

Author

Waziry, Reem, primary, Gras, Luuk, additional, Sedaghat, Sanaz, additional, Tiemeier, Henning, additional, Weverling, Gerrit J., additional, Ghanbari, Mohsen, additional, Klap, Jaco, additional, de Wolf, Frank, additional, Hofman, Albert, additional, Ikram, M. Arfan, additional, and Goudsmit, Jaap, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results